Literature DB >> 29346733

Synthesis and Structure-Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication.

Yanpeng Xing1, Jun Zuo1, Paul Krogstad1, Michael E Jung1.   

Abstract

A series of novel pyrazolopyridine compounds have been designed and prepared by a general synthetic route. Their activities against the replication of poliovirus-1, EV-A71, and CV-B3 enteroviruses were evaluated. The comprehensive understanding of the structure-activity relationship was obtained by utilizing the variation of four positions, namely, N1, C6, C4, and linker unit. From the screened analogues, the inhibitors with the highest selectivity indices at 50% inhibition of viral replication (SI50) were those with isopropyl at the N1 position and thiophenyl-2-yl unit at C6 position. Furthermore, the C4 position offered the greatest potential for improvement because many different N-aryl groups had better antiviral activities and compatibilities than the lead compound JX001. For example, JX040 with a 2-pyridyl group was the analogue with the most potent activity against non-polio enteroviruses, and JX025, possessing a 3-sulfamoylphenyl moiety, had the best activity against polioviruses. In addition, analogue JX037, possessing a novel pyrazolopyridine heterocycle, was also shown to have good antienteroviral activity, which further enlarges the compound space for antienteroviral drug design.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29346733     DOI: 10.1021/acs.jmedchem.7b01863

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Enterovirus D68 Antivirals: Past, Present, and Future.

Authors:  Yanmei Hu; Rami Musharrafieh; Madeleine Zheng; Jun Wang
Journal:  ACS Infect Dis       Date:  2020-05-14       Impact factor: 5.084

2.  Enterovirus A71 antivirals: Past, present, and future.

Authors:  Jun Wang; Yanmei Hu; Madeleine Zheng
Journal:  Acta Pharm Sin B       Date:  2021-08-20       Impact factor: 14.903

3.  Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein.

Authors:  Yanmei Hu; Naoya Kitamura; Rami Musharrafieh; Jun Wang
Journal:  J Med Chem       Date:  2021-06-04       Impact factor: 8.039

4.  Pyrazolo[4,3-c]pyridine-4-one (PP-4-one) Exhibits Anti-Epileptogenic Effect in Rat Model of Traumatic Epilepsy by Mammalian Target of Rapamycin (mTOR) Signaling Pathway Downregulation.

Authors:  Jungong Jin; Xi Shen; Lu Tian; Guoyishi He; Ying Zhang
Journal:  Med Sci Monit       Date:  2020-07-20

Review 5.  1H-Pyrazolo[3,4-b]pyridines: Synthesis and Biomedical Applications.

Authors:  Ana Donaire-Arias; Ana Maria Montagut; Raimon Puig de la Bellacasa; Roger Estrada-Tejedor; Jordi Teixidó; José I Borrell
Journal:  Molecules       Date:  2022-03-30       Impact factor: 4.411

6.  High-Pressure Metal-Free Catalyzed One-Pot Two-Component Synthetic Approach for New 5-Arylazopyrazolo[3,4-b]Pyridine Derivatives.

Authors:  AbdElAziz A Nayl; Hamada Mohamed Ibrahim; Kamal M Dawood; Wael A A Arafa; Ahmed I Abd-Elhamid; Ismail M Ahmed; Mohamed A Abdelgawad; Hazim M Ali; Ibrahim Hotan Alsohaimi; Ashraf A Aly; Stefan Bräse; Asmaa Kamal Mourad
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

7.  Inhibition of Glioma Cell Growth and Apoptosis Induction through Targeting Wnt10B Expression by Pyrazolo[4,3-c]pyridine-4-one.

Authors:  Yang Liu; Zhu Yaozu; Huang Zhao; Peng Peng; Zhang Tingbao; Chen Jincao
Journal:  Med Sci Monit       Date:  2020-11-11

8.  Enterovirus Inhibition by Hinged Aromatic Compounds with Polynuclei.

Authors:  Jih Ru Hwu; Avijit Panja; Srinivasan Jayakumar; Shwu-Chen Tsay; Kui-Thong Tan; Wen-Chieh Huang; Yu-Chen Hu; Pieter Leyssen; Johan Neyts
Journal:  Molecules       Date:  2020-08-22       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.